What Aenduo does

Aenduo S.r.l. is an Italian digital health company headquartered in Rome, founded in 2013, that develops Advantcare — a SaaS platform certified as an EU MDR Class II A medical device for managing chronic respiratory diseases across the full clinical pathway from diagnosis through follow-up. The platform is built as a modular suite spanning Remote Patient Monitoring, Remote Diagnostics (spirometry, oximetry, polysomnography, ECG), Interoperability/Automation (ERP, CRM, EMR), Clinical Management, Patient Communication, and Virtual Consultation, and is anchored on proprietary technologies including the Biopar-link connected SDK, BreathView, Respiware, and MySleep, with a co-developed Automatic Cardiac Arrhythmia Diagnosis System in partnership with Sapienza Università di Roma. The company advertises integrations with 100+ medical devices and a deployed base of 160,000+ patients, 1,000+ doctors, and 200 healthcare facilities across 8 European countries.

Aenduo operates a B2B enterprise SaaS model, selling annual subscriptions of Advantcare to healthcare facilities, homecare providers, system integrators, and European medical device manufacturers through a direct enterprise field-sales motion supported by demo requests and a multi-language website (Italian, English, French, Spanish, German). Pricing is quote-based rather than transparently published, consistent with enterprise healthcare software contracting. Revenue is not publicly disclosed, no venture funding rounds have been identified, and the company appears to be privately held by founders/management with a team of approximately 22 specialists (50% gender-balanced). The company's compliance posture — MDR Class II A, ISO 13485, ISO 27001, ISO 9001, MHRA, and GDPR — defines the regulatory perimeter within which it commercializes its software as a regulated medical device.

Name

Aenduo

Legal name

Aenduo S.r.l.

Website

https://aenduo.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

1–10 employees

Short description

Aenduo S.r.l. is a Rome-based digital health company that sells Advantcare, an EU MDR Class II A-certified SaaS platform for chronic respiratory disease management, to hospitals, homecare providers, and medical device manufacturers across 8 European countries.

Ownership category

akta.pro rank

Product category

Digital Health SaaS / Remote Patient Monitoring Software

NAICS

Custom Computer Programming Services (541511), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518)

SIC

Services-Prepackaged Software (7372), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Medical-Grade Device Connectivity & Device Management (MDM) (HLACAFAG)

akta.pro secondary industries

Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices) (HLACAPAK), EHR/EMR Integration & Interoperability Middleware (HL7/FHIR) (HLALAKAD)

Keywords

• Remote patient monitoring
• Digital health platform
• Medical device software
• Chronic respiratory care
• Healthcare interoperability

Headquarters

HQ city

Rome

HQ country

Italy

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. SaaS Platform Subscription: AdvantCare platform is offered as a SaaS template with customizable interface. The platform serves healthcare facilities and homecare providers through subscription-based licensing.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Aenduo sells Advantcare®, a SaaS-based digital health platform certified as an EU MDR Class II A medical device for chronic respiratory disease management. The platform enables remote patient monitoring, remote diagnostics (spirometry, polysomnography, oximetry, ECG), teleconsultation, automated ERP/CRM/EMR integration, and two-way patient communication for healthcare facilities, homecare providers, and system integrators. It is sold as an annual subscription on a quote-based basis to enterprise customers across 8 European countries.

Product overview

Aenduo offers the Advantcare® platform, an independent suite for chronic respiratory diseases certified as a Class II A medical device that follows the patient's entire clinical path from diagnosis to follow-up. The platform consists of multiple integrated modules including Remote Patient Monitoring, Remote Diagnostics, Interoperability and Automation, Clinical Management, and Patient Communication. Advantcare® enables remote patient management with digital tools, connects healthcare staff with patients' medical devices, and integrates with ERP/CRM/EMR systems. The company also holds several proprietary technologies and patents including Biopar-link connected SDK, BreathView, Respiware, MySleep, and an Automatic Cardiac Arrhythmia Diagnosis System developed with Sapienza Università di Roma.

Differentiator

Problem solved

Functional benefit

Products and services

• Advantcare® Manufacturer-independent SaaS suite certified as an EU MDR Class II A medical device, supporting the entire chronic respiratory patient clinical pathway from diagnosis to follow-up. Sold on an annual subscription basis to healthcare facilities, homecare providers, and system integrators across Europe, integrating remote patient monitoring, remote diagnostics, teleconsultation, ERP/CRM/EMR interoperability, and two-way patient communication in one customizable platform.

Quantifiable outcome

• 160,000+ patients connected daily for therapeutic data management
• +3 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability5 records

Feature9 records

Partnerships

Three partnerships are on record, tiered core.

• Sapienza Università di RomacoreStrategic or Co-development PartnerCollaboration on the development of an automatic cardiac arrhythmia diagnosis system. The partnership leverages academic research expertise combined with Aenduo's digital health platform capabilities.
• European Medical Device ManufacturerscoreTechnology or IntegrationCollaborations with leading European medical device manufacturers to ensure interoperability and integration of connected respiratory devices with the AdvantCare platform.
• Leading European Universities and Research InstitutescoreStrategic or Co-development PartnerOngoing R&D collaborations with leading universities and research institutes for continuous innovation in digital health technologies, including digital therapies with AI and machine learning for sleep apnea diagnosis.

Scale indicators8 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Health Recovery Solutions (HRS): Enterprise RPM platform deployed across US health systems with deep device connectivity and condition-specific pathways. Comparable to AdvantCare's enterprise healthcare facility model and chronic condition focus.
• ResMed: Global leader in connected sleep apnea and respiratory care devices (AirView, myAir) with its own RPM platform. Most directly comparable to Aenduo as a medical-device-backed respiratory SaaS solution, but vertically integrated with ResMed hardware rather than device-agnostic.
• Vivify Health: US-based RPM and chronic care management SaaS used by health systems and payers. Comparable to AdvantCare as a platform that connects patient devices, integrates EMR data, and supports condition-specific care pathways.

Broad incumbents

• Fisher & Paykel Healthcare: Major respiratory device manufacturer increasingly investing in connected care platforms for OSA, COPD, and home oxygen therapy. Comparable because it targets the same clinical workflows with its own hardware-coupled software stack.
• Linde Healthcare: Global home respiratory care provider operating both devices and care management services across Europe. Comparable on the homecare delivery side and increasingly overlaps with Aenduo's chronic respiratory patient monitoring scope.
• Philips (Sleep & Respiratory Care): Operates EncorePro/Care Orchestrator for respiratory and sleep patient management across a much broader medtech portfolio. Directly competes for hospital-side RPM deployments, but its software is part of a wide healthcare imaging and monitoring franchise rather than a specialized respiratory suite.

Regional players

• Comarch Healthcare: European health IT vendor offering telehealth, RPM, and chronic care management platforms. Comparable as a regionally focused platform competing for similar European hospital and homecare contracts across multiple therapeutic areas.
• Dedalus: European clinical software group headquartered in Italy with strong EHR, telemedicine, and care-pathway deployments across EU hospitals. Comparable as a regional incumbent that competes for the same hospital digital health budgets, though broader than respiratory.

Emerging players

• Datos Health: Israel-based remote care automation platform with device integrations and clinical workflow automation for chronic conditions. Comparable in technology stack and integration depth but broader in scope beyond respiratory.
• Biolet: European RPM provider focused on sleep apnea and respiratory home monitoring. Comparable to Aenduo as a smaller regional player pursuing similar SaaS-RPM-for-respiratory positioning in European markets.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Compliance8 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aenduo